Skip to content
TrialScanner

NCT05519059

Pelareorep and Paclitaxel Injection in Chinese Patients With Advanced or Metastatic Breast Cancer

Phase 1CompletedANLLead

Registry record

Lead sponsor
Adlai Nortye Biopharma Co., Ltd.
Conditions
Advanced or Metastatic Breast Cancer
Primary completion
Sep 29, 2022Actual
Completion
Locked
Start
Locked
Enrollment
Locked
Interventions
Locked
Study type
Locked
Results on the registry
Locked
Record last updated
Locked

Open NCT05519059 on ClinicalTrials.gov

Enrollment, interventions, the start and completion dates and the change history are locked on 1 row here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.

Unlock with TrialScanner

Recorded changes

0 changes recorded for this trial. The history, with each previous value, is part of TrialScanner.

Tracking since Nov 12, 2026. Changes before that date are not known to TrialScanner.

    NCT05519059: Pelareorep and Paclitaxel... | TrialScanner